UniSuper Management Pty Ltd Sells 1,976 Shares of Globe Life Inc. $GL

Key Points

• UniSuper Management Pty Ltd reduced its stake in Globe Life Inc. by 12.3%, selling 1,976 shares and holding 14,041 shares valued at approximately $1.85 million as of the latest SEC filing.
• Globe Life reported earnings of $3.27 per share for the most recent quarter, surpassing analysts' expectations, and has set a FY 2025 EPS guidance of 14.250-14.650.
• The company announced a quarterly dividend of $0.27 per share, with an ex-dividend date on October 3rd, representing an annualized yield of 0.8%.

UniSuper Management Pty Ltd reduced its position in Globe Life Inc. (NYSE:GL - Free Report) by 12.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,041 shares of the company's stock after selling 1,976 shares during the quarter. UniSuper Management Pty Ltd's holdings in Globe Life were worth $1,849,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also modified their holdings of the company. SouthState Corp bought a new position in shares of Globe Life in the first quarter worth approximately $43,000. SVB Wealth LLC bought a new position in shares of Globe Life in the first quarter worth approximately $63,000. Allworth Financial LP boosted its position in shares of Globe Life by 22.0% in the first quarter. Allworth Financial LP now owns 571 shares of the company's stock worth $71,000 after purchasing an additional 103 shares during the period. Versant Capital Management Inc boosted its position in shares of Globe Life by 140.2% in the first quarter. Versant Capital Management Inc now owns 586 shares of the company's stock worth $77,000 after purchasing an additional 342 shares during the period. Finally, Brooklyn Investment Group grew its holdings in Globe Life by 792.7% during the 1st quarter. Brooklyn Investment Group now owns 732 shares of the company's stock valued at $96,000 after buying an additional 650 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors.

Globe Life Trading Down 1.1%

NYSE:GL opened at $138.87 on Thursday. Globe Life Inc. has a one year low of $99.04 and a one year high of $144.00. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.06 and a current ratio of 0.06. The firm has a market cap of $11.25 billion, a P/E ratio of 11.10 and a beta of 0.56. The firm has a 50-day simple moving average of $133.57 and a 200-day simple moving average of $126.44.

Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The company reported $3.27 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.25 by $0.02. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. The firm had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter in the previous year, the firm earned $2.97 EPS. The company's quarterly revenue was up 2.9% compared to the same quarter last year. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. Equities analysts anticipate that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, October 3rd will be given a $0.27 dividend. The ex-dividend date of this dividend is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life's payout ratio is presently 8.63%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on GL shares. Morgan Stanley upped their target price on shares of Globe Life from $166.00 to $171.00 and gave the stock an "overweight" rating in a research report on Monday, August 18th. Wall Street Zen upgraded shares of Globe Life from a "hold" rating to a "buy" rating in a research report on Friday, May 16th. Cfra Research upgraded Globe Life to a "moderate buy" rating in a research report on Friday, July 25th. Wells Fargo & Company raised their target price on shares of Globe Life from $144.00 to $150.00 and gave the stock an "overweight" rating in a report on Friday, July 25th. Finally, Truist Financial began coverage on shares of Globe Life in a report on Tuesday, July 15th. They issued a "buy" rating and a $150.00 target price for the company. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, Globe Life currently has an average rating of "Moderate Buy" and a consensus price target of $152.45.

Insider Activity

In other news, CFO Thomas Peter Kalmbach sold 28,952 shares of Globe Life stock in a transaction that occurred on Tuesday, July 29th. The shares were sold at an average price of $140.97, for a total value of $4,081,363.44. Following the transaction, the chief financial officer owned 30,665 shares of the company's stock, valued at $4,322,845.05. The trade was a 48.56% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Frank M. Svoboda sold 12,500 shares of the firm's stock in a transaction dated Thursday, July 31st. The stock was sold at an average price of $141.38, for a total value of $1,767,250.00. Following the completion of the sale, the chief executive officer directly owned 32,747 shares of the company's stock, valued at approximately $4,629,770.86. This represents a 27.63% decrease in their position. The disclosure for this sale can be found here. Insiders sold 84,722 shares of company stock worth $11,733,793 in the last quarter. 1.51% of the stock is currently owned by corporate insiders.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.